NO981946L - Imidazoquinasolin derivater - Google Patents

Imidazoquinasolin derivater

Info

Publication number
NO981946L
NO981946L NO981946A NO981946A NO981946L NO 981946 L NO981946 L NO 981946L NO 981946 A NO981946 A NO 981946A NO 981946 A NO981946 A NO 981946A NO 981946 L NO981946 L NO 981946L
Authority
NO
Norway
Prior art keywords
substituted
unsubstituted
tricycloalkyl
bicycloalkyl
lower alkyl
Prior art date
Application number
NO981946A
Other languages
English (en)
Norwegian (no)
Other versions
NO981946D0 (no
Inventor
Yasuo Onoda
Yuji Nomoto
Tetsuji Ohno
Koji Yamada
Michio Ichimura
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO981946D0 publication Critical patent/NO981946D0/no
Publication of NO981946L publication Critical patent/NO981946L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO981946A 1996-08-30 1998-04-29 Imidazoquinasolin derivater NO981946L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23080796 1996-08-30
PCT/JP1997/003023 WO1998008848A1 (en) 1996-08-30 1997-08-29 Imidazoquinazoline derivatives

Publications (2)

Publication Number Publication Date
NO981946D0 NO981946D0 (no) 1998-04-29
NO981946L true NO981946L (no) 1998-06-29

Family

ID=16913591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981946A NO981946L (no) 1996-08-30 1998-04-29 Imidazoquinasolin derivater

Country Status (9)

Country Link
US (1) US6127541A (de)
EP (1) EP0863144A4 (de)
KR (1) KR19990067248A (de)
AU (1) AU724809B2 (de)
CA (1) CA2236012A1 (de)
HU (1) HUP9900790A3 (de)
NO (1) NO981946L (de)
NZ (1) NZ330292A (de)
WO (1) WO1998008848A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410584B1 (en) 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
WO1999043674A1 (en) * 1998-02-27 1999-09-02 Kyowa Hakko Kogyo Co., Ltd. Remedies for erectile dysfunction
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
US6326379B1 (en) 1998-09-16 2001-12-04 Bristol-Myers Squibb Co. Fused pyridine inhibitors of cGMP phosphodiesterase
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
US6358954B1 (en) * 1999-11-09 2002-03-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
US6576644B2 (en) 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
CA2465893A1 (en) 2001-11-09 2003-05-22 Schering Corporation Polycyclic guanine derivative phosphodiesterase v inhibitors
US20050107394A1 (en) * 2001-12-17 2005-05-19 Ardeschir Ghofrani Novel use of selective pde5 inhibitors
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
EP1699436A2 (de) * 2003-12-12 2006-09-13 Myogen, Inc. Enoximon-formulierungen und ihre verwendung bei der behandlung von herzhypertrophy und herzinsuffizienz
EP2650286A1 (de) * 2004-02-19 2013-10-16 Rexahn Pharmaceuticals, Inc. Chinazolinderivate und therapeutische Verwendung davon
CA2560528A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
JP2007530566A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｒ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
EP1776108A1 (de) * 2004-06-23 2007-04-25 Myogen, Inc. Enoximon-formulierungen und ihre verwendung bei der behandlung von pde-iii-vermittelten erkrankungen
KR20080015594A (ko) * 2006-08-16 2008-02-20 주식회사종근당 포스포디에스테라제 저해제로서 유용한 퀴나졸린 유도체 및그 제조방법
US9006252B2 (en) * 2008-09-26 2015-04-14 National Health Research Institutes Fused multicyclic compounds as protein kinase inhibitors
MX2016014384A (es) 2014-06-23 2017-01-20 Celgene Corp Apremilast para el tratamiento de una enfermedad del higado o una anormalidad en la funcion del higado.
AU2023319145A1 (en) * 2022-08-05 2025-02-13 Macquarie University Inhibitors and uses therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314884D0 (en) * 1993-07-19 1993-09-01 Zeneca Ltd Tricyclic derivatives
WO1995006648A1 (fr) * 1993-09-03 1995-03-09 Kyowa Hakko Kogyo Co., Ltd. Derive d'imidazoquinazoline
IL112248A0 (en) * 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
AU4844396A (en) * 1995-03-01 1996-09-18 Kyowa Hakko Kogyo Co. Ltd. Imidazoquinazoline derivatives

Also Published As

Publication number Publication date
US6127541A (en) 2000-10-03
CA2236012A1 (en) 1998-03-05
EP0863144A4 (de) 2001-04-11
NZ330292A (en) 2000-01-28
AU724809B2 (en) 2000-09-28
EP0863144A1 (de) 1998-09-09
AU4032397A (en) 1998-03-19
NO981946D0 (no) 1998-04-29
HUP9900790A2 (hu) 1999-06-28
KR19990067248A (ko) 1999-08-16
HUP9900790A3 (en) 2001-11-28
WO1998008848A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
NO981946L (no) Imidazoquinasolin derivater
US5223504A (en) Xanthine compounds and compositions, and methods of using them
US6153630A (en) Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same
CA2318349A1 (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
HUP0102851A2 (hu) Parazitaellenes artemizinin-származékok (endoperoxidok), eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
NO972091L (no) Bestemte substituerte benzylaminderivater; en ny klasse nouropeptid-yl-spesifikke ligander
MA26861A1 (fr) Inhibiteurs non peptidiques de la liaison cellulaire sous la dependance de vla-4 utiles dans le traitement des maladies inflammatoires, auto-immunes et respiratoires
HU194171B (en) Process for preparing asymmetric diesters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid and pharmaceuticals comprising such compounds
NO20052038L (no) Ny adeninforbindelse og anvendelse derav
NO20054224L (no) Nye 2-pyridinkarboksamidderivater
NO20041531L (no) Alkyleterderivater eller salter derav
DE69717867D1 (de) Pyrazolopyridylpyrazinon-derivate und ein verfahren zu ihrer herstellung
EP1020434A4 (de) 3-amidinoanilin-derivate, inhibitoren des aktivierten blutgerinnungsfaktors x und zwischenpodukte zur herstellung beider
NO974890D0 (no) Radicicolderivater
MX2024012320A (es) Derivado de uracilo que tiene actividad inhibidora del crecimiento viral y composicion farmaceutica que lo contiene
WO1995024392A1 (en) 2-chloro and 2-bromo derivatives of 1,5-iminosugars
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
HUP0400362A2 (hu) Antiaritmiás hatású helyettesített benzopiránszármazékok
NO952289L (no) Substituerte benzazepinoner
ATE121385T1 (de) Harnstoffderivate, ihre herstellung und ihre verwendung bei der therapie.
NO963655L (no) Nye aminosyrederivater, fremgangsmåte for fremstilling av dem og farmasöytiske blandinger som inneholder dem
US5744473A (en) PDE IV inhibitors: "bis-compounds"
EP1419771A4 (de) Mittel zur prävention und/oder behandlung von krankheiten, die auf arteriosklerotische wirkung zurückzuführen sind
FI64149C (fi) Foerfarande foer framstaellning av nya antihypertensiva pyridazinylhydrazoner
JPH0578554B2 (de)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application